Some aspects of the effects of clobazam on human psychomotor performance
- PMID: 35211
- PMCID: PMC1429540
- DOI: 10.1111/j.1365-2125.1979.tb04669.x
Some aspects of the effects of clobazam on human psychomotor performance
Abstract
1 Three studies are described, the first being a comparison of the effects of acute night-time doses of clobazam 20 mg, amylobarbitone sodium 100 mg, nitrazepam 5 mg and placebo, on choice reaction time, critical flicker fusion (CFF) and stabilometer performance. Clobazam improved early morning performance on a choice reaction test, in contrast to the other two active drugs. 2 Repeated doses of clobazam 10 mg three times daily, chlordiazepoxide 10 mg three times daily and diazepam 5 mg three times daily were given for 5 days. Again clobazam did not produce any impairment of psychomotor performance, and noticeably increased CFF thresholds. 3 The effects of an acute night-time dose of clobazam 20 mg on psychomotor performance the morning after night-time medication were correlated with the neuroticism scores (on the EPI) of the subjects. Clobazam exerts a differential effect on psychomotor performance dependent on the basic personality trait. 4 Clobazam seems to differ significantly from the 1,4-benzodiazepines in that, although it reduces anxiety, it does so without any apparent impairment of psychomotor performance.
Similar articles
-
Clobazam. A 1.5 benzodiazepine derivative: effects upon human psychomotor performance under different levels of task reinforcement.Arch Int Pharmacodyn Ther. 1978 Apr;232(2):261-8. Arch Int Pharmacodyn Ther. 1978. PMID: 28096 Clinical Trial.
-
The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication.Arzneimittelforschung. 1978;28(11):2169-72. Arzneimittelforschung. 1978. PMID: 40568
-
The effects of triazolam and nitrazepam on sleep quality, morning vigilance and psychomotor performance.Arzneimittelforschung. 1980;30(7):1163-6. Arzneimittelforschung. 1980. PMID: 6106500 Clinical Trial.
-
Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.Drugs. 1980 Sep;20(3):161-78. doi: 10.2165/00003495-198020030-00001. Drugs. 1980. PMID: 6107238 Review.
-
A review of the effects of diazepam on cognitive and psychomotor performance.J Nerv Ment Dis. 1975 Dec;161(6):399-414. doi: 10.1097/00005053-197512000-00004. J Nerv Ment Dis. 1975. PMID: 1104773 Review.
Cited by
-
Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice.Br J Clin Pharmacol. 1979;7 Suppl 1(Suppl 1):113S-118S. doi: 10.1111/j.1365-2125.1979.tb04676.x. Br J Clin Pharmacol. 1979. PMID: 35189 Free PMC article. Clinical Trial.
-
Pharmacodynamic effects of buspirone and clobazam.Br J Clin Pharmacol. 1991 Jul;32(1):91-7. doi: 10.1111/j.1365-2125.1991.tb05618.x. Br J Clin Pharmacol. 1991. PMID: 1679659 Free PMC article. Clinical Trial.
-
The effect of clobazam and lorazepam on the psychomotor performance of anxious patients.Br J Clin Pharmacol. 1983 Jul;16(1):95-9. doi: 10.1111/j.1365-2125.1983.tb02149.x. Br J Clin Pharmacol. 1983. PMID: 6136292 Free PMC article.
-
The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety.Br J Clin Pharmacol. 1979 Oct;8(4):325-9. doi: 10.1111/j.1365-2125.1979.tb04713.x. Br J Clin Pharmacol. 1979. PMID: 41548 Free PMC article. Clinical Trial.
-
The effects of fall-risk-increasing drugs on postural control: a literature review.Drugs Aging. 2013 Nov;30(11):901-20. doi: 10.1007/s40266-013-0113-9. Drugs Aging. 2013. PMID: 24005984 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources